Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. (LXRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LXRX · as of Jun 8, 2026
Key Statistics
Explore Lexicon Pharmaceuticals, Inc. Data
lxrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 35.7%
The LXRX analyst consensus is Hold, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +214.14% upside from the current price of $1.91.
Competitors & Peers
lxrx competitorsLXRX
ADCT
BCYC
CMPX
FDMT
FULCStock Performance
Full HistoryAbout Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates…
what is lexicon pharmaceuticals, inc. · lxrx stock overview · lexicon pharmaceuticals, inc. company profile · who is lexicon pharmaceuticals, inc. ceo · lxrx NASDAQ · lexicon pharmaceuticals, inc. headquarters · lexicon pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Lexicon Pharmaceuticals, Inc. (LXRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 7, 2000. As of the latest trading session, LXRX stock price is $1.91, with a market capitalization of $848.4M. The stock has returned +156.34% over the past 12 months and +66.09% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Lexicon Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $6.00. In fiscal year 2025, Lexicon Pharmaceuticals, Inc. reported revenue of $49.8M and net income of -$50.3M. For detailed data — including Lexicon Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lexicon Pharmaceuticals, Inc. (LXRX) stock price is $1.91. The stock is traded on NASDAQ under the ticker symbol LXRX. The 52-week range is $0.64 – $2.53.